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The present systematic review and meta-analysis was conducted to investigate the effects of 
ginger supplementation on markers of inflammatory and oxidative stress. PubMed, Embase, 
Scopus and Web of Science were systematically searched to identify relevant clinical trials 
evaluating the effects of ginger on serum CRP (C-reactive protein), TNF-α (tumor necrosis 
factor‐alpha), IL-6 (interleukin-6), PGE2 (Prostaglandin E2), TAC (Total antioxidant capacity) 
and MDA (Malondialdehyde) from inception up to September 2019. Mean difference (MD) and 
its 95 % confidence interval (CI) was determined using a random effects model. Potential 
publication bias was assessed using visual inspection of funnel plot and Egger's weighted 
regression tests. After excluding irrelevant records, 20 full-text articles that included 25 separate 
studies were included to the meta-analysis. Pooled results of the present study indicated a 
statistically significant effect of ginger on serum CRP, TNF-α, IL-6, TAC and MDA levels 
following ginger supplementation. Also, the effects of ginger on serum PGE2 was marginally 
significant. Moreover, the significant heterogeneity disappeared in subgroup analysis performed 
by age, duration, dosage, and quality. This current analysis indicates that ginger supplementation 
has significant effects on serum inflammatory markers. 
Keywords: ginger, zingiber, inflammation, stress oxidative, meta-analysis 
1 Introduction 
Low grade systematic inflammation is a complex response that plays an important role in 
numerous conditions, that include: metabolic syndrome (Safranow et al., 2016), cardiovascular 
disease (CVD) (Guarner & Rubio-Ruiz, 2015), type 2 diabetes (Donath, 2019), lung diseases (Di 
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Rosanna & Salvatore, 2012) and different types of cancer (Grivennikov, Greten, & Karin, 2010).  
C-reactive protein (CRP) is an acute phase protein secreted by the liver in response to other pro-
inflammatory cytokines including tumor necrosis factor‐alpha (TNF-α) and interleukin‐6 (IL-6) 
released by macrophages and lymphocyte (Gabay, 2006; Pepys & Hirschfield, 2003). 
Overproduction of TNF-α and IL-6 contributes to effects on skeletal muscle and adipose tissue 
(Stanley et al., 2011). Prostaglandin E2 (PGE2) is a potent inflammatory mediator produced 
from arachidonic acid (AA) by cyclooxygenase 2 (COX2) (Harizi, Corcuff, & Gualde, 2008). A 
growing body of evidence suggests that PGE2 is involved in the progression of acute and chronic 
inflammation and autoimmune diseases (Tsuge, Inazumi, Shimamoto, & Sugimoto, 2019). In 
addition, elevated markers of oxidative stress, that may result from increasing reactive oxygen 
species and free radicals have been suggested to be involved in the etiology of several chronic 
diseases (Daenen et al., 2019; Liguori et al., 2018). 
Dietary interventions, particularly those that are plant based, have been proposed as alternative 
treatments to improve low-grade inflammation and oxidative stress (Arabzadegan et al., 2019; 
Pastori et al., 2015). Ginger has been used both as a food and as an herbal medicine for 
thousands of years. Ginger is the root of Zingiber officinal, and it contains several compounds 
such as gingerol, zingerone, shogaol, paradols, and β-bisabolene (Sahebkar, 2011). Studies have 
shown that ginger possesses antioxidant, antihypertensive, cardioprotective, antidiabetic, 
antimicrobial, gastroprotective, anticancer, chemopreventive health benefits (Ali, Blunden, 
Tanira, & Nemmar, 2008; Baliga et al., 2011). In addition, consumption of ginger appears to 
modulate inflammatory responses, which may result from inhibition of the activity of COX 
enzymes, and block the production of interleukins, and TNF-a in activated macrophages 
(Kafeshani, 2015; Liguori et al., 2018). 
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In several randomized controlled trials (RCTs), ginger supplementation has been shown to affect 
biomarkers of inflammation and oxidative stress (Kulkarni & Deshpande, 2016; Naderi, 
Mozaffari-Khosravi, Dehghan, Nadjarzadeh, & Huseini, 2016; Zehsaz, Farhangi, & Mirheidari, 
2014; Zick et al., 2015). However, these findings are inconsistent, other studies have not found 
significant effects of ginger on oxidative stress and inflammatory biomarkers (Azimi, Ghiasvand, 
Feizi, Hariri, & Abbasi, 2014; Imani et al., 2015). These inconsistencies could be the result of 
small sample size and varied quality of the studies. It is expected that the ginger supplementation 
could have beneficial effects on some biomarkers of inflammation and oxidative stress. 
Therefore, we conducted a meta-analysis to obtain a pooled estimate of the effect of ginger 
supplementation on biomarkers of inflammation and oxidative stress in clinical trials, and also to 
assess whether an administration of ginger could ameliorate antioxidant and inflammation status. 
2 Method 
The present meta-analysis was conducted based on the Preferred Reporting Items for Systematic 
reviews and Meta-Analyses (Moher, Liberati, Tetzlaff, & Altman, 2009). 
2.1 Data sources and search strategy 
Online databases (PubMed, Embase, Scopus and Web of Science) were systematically searched 
by two independent reviewers (MJ and ZM) to find related papers that assessed the effects of 
ginger supplementation on improvement of inflammatory and oxidative stress markers from 
incent up to 18 September 2019, without any restriction on the language and time of publication. 
The following search terms were used in titles and abstracts: (ginger OR zingiber OR “Zingiber 
officinale” OR “zingiberene” OR “β-bisabolene” OR “α-farnesene” OR “β-sesquiphellandrene” 
OR “α-curcumene”) AND ("inflammation" OR "inflamma*" OR "inflammatory" OR IL-6 OR 
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interleukin-6 OR “interleukin 6” OR interleukin6 OR IL6 OR “IL 6” OR "CRP" OR “hs-CRP” 
OR "C-reactive protein"  OR “TNF-α” OR “TNFα” OR “TNF α” OR “tumor necrosis factor-α” 
OR “tumor necrosis factor α” OR “tumor necrosis factor α” OR “tumor necrosis factor alpha” 
OR “TNF-alpha” OR "PGE*" OR "prostaglandin" OR “MDA” OR “Malondialdehyde” OR 
“TAC” OR “Total antioxidant capacity”) AND ("trial" OR "randomi*" OR "control" OR 
"clinical" OR "intervention" OR "randomized" OR "placebo" OR "blind" OR "supplement*"). 
Furthermore, the wild-card term “*” was used to increase the sensitivity of the search strategy. 
EndNote X9 was used to moderate the literature screening and duplicates finding. Also, hand 
searching was done using the list of references, Google Scholar and Cochrane Library. 
2.2 Inclusion and Exclusion criteria 
Studies were included that met the following characteristics: (1) a clinical trial with any kind of 
design, (2) using ginger without no other nutrients as a supplement in adults (> 18 years old), (3) 
reporting a change of at least one of outcomes including CRP, TNF-α, IL-6, PGE2, TAC or 
MDA and (4) having more than 10 days’ intervention duration. Non-English language trials, 
animal studies and papers which their data were not convertible were excluded.  
2.3 Data selection 
After deletion of duplicate records, two authors (MJ and ZM) independently reviewed the 
remained studies to determine their suitability for inclusion. Screening process was performed in 
two stages. At first, title/abstract of articles were scanned, publications that were irrelevant were 
excluded. Then, the remaining articles were evaluated for eligibility using full text in the second 
stage. the following data were extracted using pre-defined list including the first authors’ last 
name, location of trial, sample size, age, dosage of ginger, type of supplement, duration of the 
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intervention, and quality of the included articles by AM and RJ, independently. Any doubts were 
resolved by MJ. 
2.4 Quality evaluation 
The Jadad scale with a maximum of 5 points (randomization: 2, blinding: 2 and dropouts 
descriptive: 1) was used to assess the quality of the trials. Trials scoring <3 were considered as 
low quality studies and the rest as high quality (Clark et al., 1999). 
2.5 Statistical analysis 
Stata V13 was used to analyze all data. Forest plot, in which results from individual trials were 
displayed as a square and a horizontal line, representing the ginger effect estimate together with 
its 95% confidence interval.  The meta-analyses measure of effect and its confidence interval 
were represented by a diamond and the lateral points, respectively. In case of heterogeneity, 
fixed or random effects models were executed to calculate mean difference (MD) and its 95% 
confidence interval (CI). A significant and high heterogeneity was assessed using p value < 0.05 
and I2 ≥ 50%, respectively. Moreover, subgroup analysis was done by age, dosage, intervention 
duration and quality. Net changes in outcomes were calculated by subtracting the value at 
baseline from that after intervention in the active-treated groups and in the control ones. SDs of 
the mean difference were obtained as the following procedure: SD = square root [((SD pre)2 + 
(SD post)2) – (2r × SD pre × SD post)], considering a correlation coefficient (r) = 0.5 for both 
pre-tests / post-tests. In case of those studies that reported standard error (SE), SD was obtained 
using this formula: (SD = SE × √n). Sensitivity analysis was performed to find the effect of each 
study on the pooled result.  Publication bias was examined using Egger's regression test, and 
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visual inspection of funnel plot when the number of studies was more than 10. A p value < 0.05 
was considered as statistically significant. 
3 Results 
3.1 Data selection 
The flowchart of data selection process is presented in Figure 1. At first, 1128 records were 
identified using the strategy search of online databases (PubMed, Embase, Scopus and Web of 
Sciences). After finding duplicates, 529 references were screened by title and abstract. At the 
next step, 469 records were excluded and 60 full-text articles were assessed for eligibility. 
Finally, 20 articles considering 25 separate studies with different characteristics were included in 
this meta-analysis (Arablou et al., 2014; Atashak, Peeri, Azarbayjani, Stannard, & Haghighi, 
2011; Ayaz & Roshan, 2012; Azimi et al., 2014; Black, Herring, Hurley, & O'Connor, 2010; Di 
Rosanna & Salvatore, 2012; Grivennikov et al., 2010; Guarner & Rubio-Ruiz, 2015; 
Hunninghake et al., 1984; Imani et al., 2015; Kulkarni & Deshpande, 2016; Kumar, Singh, 
Saxena, & Saxena, 2013; Mahluji, Ostadrahimi, Mobasseri, Ebrahimzade Attari, & Payahoo, 
2013; Mozaffari-Khosravi, Naderi, Dehghan, Nadjarzadeh, & Fallah Huseini, 2016; Naderi et al., 
2016; Rahimlou, Yari, Hekmatdoost, Alavian, & Keshavarz, 2016; Safranow et al., 2016; Vahdat 
Shariatpanahi et al., 2013; Zehsaz et al., 2014; Zick et al., 2015). 
3.2 Trial characteristics: 
Characteristics of included clinical trials are shown in Table 1. These studies were published 
from 2010 to 2016. Of these 19 studies, 4 were conducted in the USA (Black et al., 2010; Zehsaz 
et al., 2014; Zick et al., 2015), 13 in Iran (Arablou et al., 2014; Atashak et al., 2011; Ayaz & 
Roshan, 2012; Azimi et al., 2014; Di Rosanna & Salvatore, 2012; Grivennikov et al., 2010; 
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Guarner & Rubio-Ruiz, 2015; Hunninghake et al., 1984; Imani et al., 2015; Mahluji et al., 2013; 
Mozaffari-Khosravi et al., 2016; Naderi et al., 2016; Rahimlou et al., 2016; Safranow et al., 
2016; Vahdat Shariatpanahi et al., 2013), and 2 in India (Kulkarni & Deshpande, 2016; Kumar et 
al., 2013). Overall, 446 and 442 subjects participated in the intervention and control groups, 
respectively. The participants’ age range was between 20-58 years old and also the range of 
intervention duration was between 10 days to 3 months.  The minimum and maximum dosage 
were 0.12 g/day and 3 g/day of ginger, respectively. Four of the included studies were considered 
as low quality (Ayaz & Roshan, 2012; Kulkarni & Deshpande, 2016; Kumar et al., 2013; 
Safranow et al., 2016) and the other 15 were considered as high quality ones (Arablou et al., 
2014; Atashak et al., 2011; Azimi et al., 2014; Black et al., 2010; Di Rosanna & Salvatore, 2012; 
Grivennikov et al., 2010; Guarner & Rubio-Ruiz, 2015; Hunninghake et al., 1984; Imani et al., 
2015; Kulkarni & Deshpande, 2016; Mahluji et al., 2013; Mozaffari-Khosravi et al., 2016; 
Naderi et al., 2016; Rahimlou et al., 2016; Vahdat Shariatpanahi et al., 2013; Zehsaz et al., 2014; 
Zick et al., 2015).  
3.3 The effect of ginger supplementation on inflammatory markers: 
As indicated in Figure 2A, the meta-analysis on 285 subjects in the intervention group and 280 
subjects in the control group showed a significant reduction in serum CRP after ginger 
supplementation (MD = -1.032, 95% CI = [-1.533, -0.531], P < 0.0001) with a high 
heterogeneity among the included studies (I2 = 86.0%, P < 0.0001). The significant heterogeneity 
disappeared in the subgroup analysis: age (less than 30 years, 30-40 years and more than 50 
years), doses up to 1 g/d and quality (low quality). No potential publication bias (Figure 5) was 
found (P = 0.635). 
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The forest plot of 7 effect sizes (Figure 2B) showed a significant change in serum TNF-α after 
ginger supplementation as compared with the control group (MD = -0.950, 95% CI = [-1.588, -
0.312], P = 0.004) with a significant heterogeneity among the studies (I2 = 88.1%, P < 0.0001). 
Based on the subgroup analysis, heterogeneity was reduced in duration (up to one month). No 
significant publication bias was identified (P = 0.197). 
The pooled effect estimate of 5 datasets (Figure 2C) indicated a significant reduction in serum 
IL-6 following ginger supplementation in comparison with the control group (MD = -1.025, 95% 
CI = [-1.710, -0.339], P = 0.003). A significant heterogeneity was observed in this meta-analysis 
(I2 = 72.8%, P = 0.005). In subgroup analysis, a reduction of heterogeneity was found for age (40 
– 50 years). No evidence of a significant publication bias was found (P = 0.274). 
This meta-analysis (Figure 2D) showed that ginger supplementation had a marginally significant 
effect on serum PGE2 as compared to the control group (MD = -0.316, 95% CI = [-0.632, -
0.000], P = 0.050). No evidence of a high heterogeneity was found among the included effect 
sizes (I2 = 0.0%, P = 0.475). 
3.4 The effect of ginger supplementation on stress oxidative: 
The pooled effect estimate of 5 datasets (Figure 3A) showed a significant change of serum TAC 
following ginger supplementation as compared to the control group (MD = 0.933, 95% CI = 
[0.652, 1.334], P < 0.0001). A high degree of heterogeneity was observed among studies in the 
overall effects (I2 = 95.2%, P < 0.0001). Evidence of a significant publication bias was not found 
(P = 0.760).  
The forest plot of 7 effect sizes (Figure 3B) indicated a significant reduction of serum MDA after 
ginger supplementation as compared to the control group (MD = -0.652, 95% CI = [-1.278, -
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0.027], P = 0.041). A high degree of overall heterogeneity (I2 = 82.7%, P < 0.0001) was reduced 
in the subgroup analysis that was performed by duration of exposure (10 weeks), dosage (Less 
than 1.5 g/day) and quality (Low quality) of the trials. No significant publication bias was found 
in this meta-analysis (P = 0.168). 
3.5 Sensitivity analysis: 
Results of sensitivity analyses showed that removal of none of the studies could affect the 
significance of pooled results (Figure 4). 
4 Discussion 
The present systematic review and meta-analysis assessed the influence of ginger 
supplementation on serum CRP, TNF-α, PGE2, IL-6, TAC and MDA concentrations from 
available RCTs. The meta-analysis of data from nineteen RCTs revealed a significant effect of 
ginger supplementation on plasma CRP, TNF-α, PGE2 and IL-6 concentrations. However, a 
significant reduction was observed in the circulating CRP and TNF-α at doses 2-3 g/day and 1-2 
g/day, respectively.  This means that the higher dosage of ginger supplementation had a potential 
effect on lowering plasma inflammatory cytokines. The anti-inflammatory effect of ginger has 
been  investigated in previous studies (Arablou et al., 2014; Kim, Chun, Kundu, & Surh, 2004). 
However, these findings are inconsistent.  The variability of results in these studies may be 
attributed to the differences in study design, quality of studies, supplemental duration, individual 
characteristics, and ginger dose. NF-kβ is the key regulator of the inflammatory process. It has 
been shown that NF-kβ activates the expression of inflammatory target genes, including genes 
encoding cytokines, chemokines, and the enzyme cyclooxygenase 2 (COX2). Among them, 
COX2 leads to the formation of prostaglandins in response to inflammation and enhanced the 
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production of pro-inflammatory cytokines. Several studies have shown that ginger has a potential 
anti-inflammatory activity and inhibited inflammatory response by suppression of the NF-kβ 
activation, thereby it could reduce the expression of cytokine genes (TNF- and IL-6) (Wang, Ke, 
Bao, Hu, & Chen, 2017). The TNF-α lowering effect of ginger has been shown in some studies; 
this is consistent with our findings (Luettig et al., 2016; Sherif, Abas, Zaitoun, & Technology, 
2018) A recent meta-analysis has reported that acute-phase proteins including CRP were also 
suppressed in this process (Mazidi, Gao, Rezaie, & Ferns, 2016). Naderi et al. showed that 
ginger powder supplementation at a dose of 1 g/d for 12-week decreased inflammatory markers, 
that included serum CRP in patients with knee osteoarthritis (Naderi et al., 2016), which is 
consistent with the results of a study by Rahimlou et al. (Rahimlou et al., 2016). Moreover, the 
other anti-inflammatory effects of ginger are caused by its inhibitory effect on COX-2 and 
lipoxygenase, thereby suppressing arachidonic acid metabolism. Therefore, it reduced platelet 
aggregation, formation of pro-inflammatory thromboxane, and prostaglandin. It was shown that 
ginger had anti-inflammatory effects through inhibition of prostaglandin synthesis (Azimi et al., 
2014). The study carried out by Phan et al. showed that ginger inhibited the formation of nitric 
oxide and inflammatory cytokines, the enzyme prostaglandin synthase; therefore, it could 
decrease inflammation (Phan et al., 2005). In an animal study by Thomson et al., it was also 
demonstrated that consumption of 500 mg/kg ginger for 4 weeks decreased serum prostaglandin 
E2 through the inhibitory effect of ginger on prostaglandin (Thomson et al., 2002). 
Several compounds in ginger are responsible for serotonin blocker which is related to the 
reduction of TNFα, IL1β, IL6, IL2, and prostaglandins (Aryaeian & Tavakkoli, 2015). Some 
studies also indicated the effects of ginger supplementation on inflammatory cytokines. In 
agreement with our findings, 500mg of ginger powder resulted in the reduction of plasma IL-1β, 
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IL-6, and TNF-α in male endurance runners who had consumed 500 mg of ginger powder (Mao 
et al., 2019). Several other studies have also demonstrated this beneficial effect (Azimi et al., 
2014; Mashhadi et al., 2013; Suk et al., 2017). 
Moreover, our subgroup analysis showed that ginger supplementation had a lowering effect o 
serum TNF-α and CRP in interventions with a duration 2-3 months. Thus, a higher efficacy of 
supplementation was observed in trials with higher duration than shorter duration. 
The pooled effect of several studies also showed a significant mean difference for the serum 
levels of TAC and MDA. It has been shown that ginger had potential antioxidant properties due 
to high amount of phenolic compounds (Attia, Ibrahim, Nabil, & Aziz, 2013). Ginger 
supplementation potentiates the antioxidant defense system through the activation of nuclear 
factor erythroid 2 (NFE2)-related factor 2 (Nrf2) and the expression of several antioxidant 
enzymes and thereby could reduce the generation of ROS and lipid peroxidation. Therefore, it 
protected against oxidative stress and prevented the depletion of antioxidants (Al Hroob, 
Abukhalil, Alghonmeen, & Mahmoud, 2018; Mao et al., 2019) which lead to markedly lower 
MDA concentration (Attia et al., 2013).  
This is the first systematic review and meta-analysis to investigate the effect of ginger 
supplementation on inflammatory and oxidative stress biomarkers. However, two limitations of 
our study should be noted.  First, in most of the studies included, findings were not adjusted for 
potential confounders, which could potentially influence results. Second, subjects in these studies 
had a diverse set of health conditions. Moreover, ginger is a popular spice with negligible side 
effects and most of the references have reported no side effect of ginger consumption (Black et 
al., 2010; Imani et al., 2015; Shidfar et al., 2015; Zick et al., 2015), however, few studies have 
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demonstrated that some anti-inflammatory compounds of ginger (gingerdiones and shogoals) 
have fewer adverse effect (Mahluji et al., 2013; Zehsaz et al., 2014). 
 
5 Conclusion  
Ginger supplementation may improve the anti-inflammatory and antioxidant status.  However, 
further large well‐designed studies are warranted to support the finding. 
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Black 1 2010 USA raw Healthy adults 17 / 17 21.1 (0.7) 11 d 2 
High 
quality 
Black 2 2010 USA heated Healthy adults 20 / 20 20.6 (0.6) 11 d 2 
High 
quality 
Atashak 1 2011 Iran capsule Obese men 8 / 8 23.66 (3.39) 10 w 1 High quality 
Atashak 2 2011 Iran capsule Obese men 8 / 8 23.71 (3.81) 10 w 1 High quality 
Ayaz 1 2012 Iran capsule Women with breast cancer 10 / 10 46.4 (5.5) 6 w 2.25 
Low 
quality 
Ayaz 2 2012 Iran capsule Women with breast cancer 10 / 10 47.5 (4.6) 6 w 2.25 
Low 
quality 





36 / 35 20 - 58 4 w 0.5 Low quality 














16 / 16 41.19 (3.69) 10 d 0.12 High quality 
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Arablou 2014 Iran capsule T2DM patients 33 / 30 52.6 (8.4) 12 w 1.6 
High 
quality 
Atashak 1 2014 Iran Capsule Obese men  8 / 8 23.66 (3.39) 10 w 1 Low quality 
Atashak 2 2014 Iran Capsule  Obese men 8 / 8 23.71 (3.81) 10 w 1 Low quality 
Azimi 2014 Iran raw-powder 
T2DM 
patients 41 / 39 55.21 (1.1) 8 w 3 
High 
quality 





14 / 14 23.21 (2.77) 12 w 1.5 High quality 
Attari 2015 Iran Tablet Obese women 39 / 31 
35.25 (7.30) 
 
12 w 2 High quality 




18 / 18 56 (2.5) 10 w 1 High quality 
Khandouzi 2015 Iran Capsule 
Type 2 
diabetic 
22 / 19 45.20 (7.64) 12 w 2 High quality 
Shidfar 2015 Iran capsule T2DM patients 22 / 23 45.2 (7.64) 12 w 3 
High 
quality 







10 / 10 51.1 (11.7) 28 d 2 High quality 








50 / 50 57.98 (6.2) 12 w 0.5 High quality 




50 / 50 57.98 (6.2) 12 w 0.5 High quality 






23 / 21 45.45 (2.3) 12 w 2 High quality 
Nikkhah 2019 Iran Capsule Patients 
with 






SD: standard deviation, W: week, D: day, T2DM: type 2 diabetes mellitus 
 
 
Table 2. The effect of ginger supplementation on CRP, TNF-α, IL-6 and PGE2 by age, duration, 
dosage and quality of the studies 
CRP 
Subgroups Effect size 95% CI P value 
I2 
heterogeneity 






2 -2.168, 0.177 0.096 58.1% 0.122 





0.0001 0.0% 0.502 
40 – 50 
years 3 
-4.405, 









1 -1.665, -0.657 
< 
0.0001 - - 
1 - 2 
months 4 
-1.271, 
-0.027 0.041 70.0% 0.018 
2 – 3 
months 7 
-2.096, 
-0.436 0.003 90.2% < 0.0001 
Dosage 
Up to 1 
g/d 5 
-1.231, 
-0.325 0.001 57.4% 0.052 
1 – 2 
g/d 3 
-4.018, 
0.118 0.065 96.5% < 0.0001 
2 – 3 
g/d 4 
-1.606, 
















1 -1.687, -0.126 0.023 - - 
30 – 40 
years 1 
-0.536, 
0.409 0.792 - - 
40 – 50 
years 3 
-2.948, 











2 -0.548, 0.235 0.433 0.0% 0.490 
1 - 2 
months 1 
-0.971, 
0.110 0.118 - - 
2 – 3 
months 4 
-2.447, 
-0.527 0.002 89.6% < 0.0001 
Dosage 
Up to 1 
g/d 2 
-1.979, 
0.115 0.081 84.% 0.011 
1 – 2 
g/d 4 
-2.295, 
-0.175 0.022 90.5% < 0.0001 
2 – 3 
g/d 1 
-0.536, 






1 -2.617, -0.860 
< 
0.0001 - - 
30 – 40 
years 2 
-3.120, 
0.197 0.084 80.3% 0.024 
40 – 50 
years 2 
-0.835, 




- - - - - 
Dosage 
Up to 1 
g/d 1 
-1.233, 
0.178 0.143 - - 
1 – 2 
g/d 2 
-2.364, 
0.378 0.156 85.9% 0.008 
2 – 3 
g/d 2 
-3.120, 









-0.035 0.040 72.6% 0.026 










Table 3. The effect of ginger supplementation on TAC and MDA by age, duration, dosage and 
quality of the studies 
 
TAC 
Subgroups Effect size 95% CI P value 
I2 
heterogeneity 










3 0.915, 2.006 
< 






















3 1.030, 1.793 
< 

















4 -1.505, -0.475 
< 




































0.126 0.099 88.2% < 0.0001 

























Figure 4. The results of sensitivity analysis of CRP (A), TNF-α (B), IL-6 (C), PGE2 (D), TAC 




Figure 5. Funnel plot for the efficacy of ginger supplementation on serum CRP levels 
